GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BNR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Burning Rock Biotech Limited stock price down 0% on Thursday
(Updated on Apr 18, 2024)

Buy or Hold candidate since Apr 11, 2024 Gain 5.26% PDF

No changes to the price of Burning Rock Biotech Limited stock on the last trading day (Thursday, 18th Apr 2024). During the last trading day the stock fluctuated 5.45% from a day low at $0.770 to a day high of $0.81. The price has risen in 6 of the last 10 days and is up by 11.97% over the past 2 weeks.

Given the current short-term trend, the stock is expected to fall -19.21% during the next 3 months and, with a 90% probability hold a price between $0.492 and $0.646 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BNR Signals & Forecast

Mostly positive signals in the chart today. The Burning Rock Biotech Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.776 and $0.749. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, March 15, 2024, and so far it has risen 17.65%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Burning Rock Biotech Limited stock

Burning Rock Biotech Limited finds support from accumulated volume at $0.799 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0420 between high and low, or 5.45%. For the last week, the stock has had daily average volatility of 10.15%.

Our recommended stop-loss: $0.762 (-4.72%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 23 days ago.)

Trading Expectations (BNR) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Burning Rock Biotech Limited to open at $0.794, and during the day (based on 14 day Average True Range), to move between $0.727 and $0.87, which gives a possible trading interval of +/-$0.0727 (+/-9.09%) up or down from last closing price. If Burning Rock Biotech Limited takes out the full calculated possible swing range there will be an estimated 18.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.799 (0.11%) than the resistance at $0.80 (0.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Burning Rock Biotech Limited stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.320 Buy Candidate Unchanged

Predicted Opening Price for Burning Rock Biotech Limited of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.794 ( 0.750%) $0.80

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BNR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.84 4.50 %
R2 0.82 2.49 %
R1 0.81 1.26 %
Current price: 0.80
Support S1 0.778 -2.76 %
S2 0.768 -3.99 %
S3 0.752 -6.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.82 2.51 %
R2 0.81 1.01 %
R1 0.80 0.562 %
Current price 0.80
Support S1 0.799 -0.113%
S2 0.780 -2.49%
S3 0.700 -12.50%

FAQ

What is the symbol for Burning Rock Biotech Limited Stock and on which exchange is it traded?
The symbol for Burning Rock Biotech Limited is BNR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Burning Rock Biotech Limited Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Burning Rock Biotech Limited Stock?
Burning Rock Biotech Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Burning Rock Biotech Limited Stock.

What's the current price of Burning Rock Biotech Limited Stock?
As of the end of day on the 2024-04-18, the price of an Burning Rock Biotech Limited (BNR) share was $0.80.

What is the 52-week high and low for Burning Rock Biotech Limited Stock?
The 52-week high for Burning Rock Biotech Limited Stock is $3.25 and the 52-week low is $0.572.

What is the market capitalization of Burning Rock Biotech Limited Stock?
As of the 2024-04-18, the market capitalization of Burning Rock Biotech Limited is 78.019M.

When is the next earnings date for Burning Rock Biotech Limited?
The upcoming earnings date for Burning Rock Biotech Limited is May 28, 2024.
Click to get the best stock tips daily for free!

About Burning Rock Biotech Limited

Burning Rock Biotech Limited Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestina... BNR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT